UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 211

Sortiert nach

Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

Nature (London), 2018-12, Vol.564 (7735), p.273-277

2018

Link zum Volltext

Verfügbarkeit prüfen

CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia

PloS one, 2013-04, Vol.8 (4), p.e61338

2013

Link zum Volltext

Verfügbarkeit prüfen

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

Haematologica (Roma), 2021-04, Vol.106 (4), p.978-986

2021

Link zum Volltext

Verfügbarkeit prüfen

CAR models: next-generation CAR modifications for enhanced T-cell function

Molecular therapy. Oncolytics, 2016, Vol.3 (C), p.16014-16014, Article 16014

2016

Link zum Volltext

Verfügbarkeit prüfen

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

Haematologica (Roma), 2018-09, Vol.103 (9), p.e424-e426

2018

Link zum Volltext

Verfügbarkeit prüfen

Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes

The Journal of clinical investigation, 2021-01, Vol.131 (2), p.1-10

2021

Link zum Volltext

Verfügbarkeit prüfen

Deletion of Cbl-b inhibits CD8+ T-cell exhaustion and promotes CAR T-cell function

Journal for immunotherapy of cancer, 2021-01, Vol.9 (1), p.e001688

2021

Link zum Volltext

Verfügbarkeit prüfen

4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells

Journal for immunotherapy of cancer, 2021-10, Vol.9 (10), p.e003354

2021

Link zum Volltext

Verfügbarkeit prüfen

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies

International journal of hematology, 2014-04, Vol.99 (4), p.361-371

2014

Link zum Volltext

Verfügbarkeit prüfen

VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and Rearrangements

Frontiers in immunology, 2018-05, Vol.9, p.976-976

2018

Link zum Volltext

Verfügbarkeit prüfen

Biology and clinical application of CAR T cells for B cell malignancies

International Journal of Hematology, 2016-07, Vol.104 (1), p.6-17

2016

Link zum Volltext

Verfügbarkeit prüfen

CAR T cells find strength in polyfunction

Blood, 2018-08, Vol.132 (8), p.769-770

Davila, Marco L.

2018

Link zum Volltext

Verfügbarkeit prüfen

Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies

Stem cells (Dayton, Ohio), 2018-01, Vol.36 (1), p.36-44

2018

Link zum Volltext

Verfügbarkeit prüfen

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

Molecular therapy. Oncolytics, 2023-12, Vol.31, p.100751-100751, Article 100751

2023

Link zum Volltext

Verfügbarkeit prüfen

Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy

Journal for immunotherapy of cancer, 2022-07, Vol.10 (7), p.e004938

2022

Link zum Volltext

Verfügbarkeit prüfen

CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia

Clinical advances in hematology & oncology, 2016-10, Vol.14 (10), p.802-808

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Science translational medicine, 2014-02, Vol.6 (224), p.224ra25

2014

Link zum Volltext

Verfügbarkeit prüfen

Advances in CAR T cell clinical development

Best practice & research. Clinical haematology, 2021-09, Vol.34 (3), p.101307-101307, Article 101307

2021

Link zum Volltext

Verfügbarkeit prüfen

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

International journal of radiation oncology, biology, physics, 2019-12, Vol.105 (5), p.1012-1021

2019

Link zum Volltext

Verfügbarkeit prüfen

Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma

EJHaem, 2022-02, Vol.3 (1), p.223-227

2022

Link zum Volltext

Verfügbarkeit prüfen

At The Bedside: Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies

Journal of leukocyte biology, 2016-12, Vol.100 (6), p.1265-1272

2016

Link zum Volltext

Verfügbarkeit prüfen

Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience

Molecular therapy. Methods & clinical development, 2018-09, Vol.10, p.371-378

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(189)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

CAR models: next-generation CAR modifications for enhanced T-cell function

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes

Deletion of Cbl-b inhibits CD8+ T-cell exhaustion and promotes CAR T-cell function

4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies

VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and Rearrangements

Biology and clinical application of CAR T cells for B cell malignancies

CAR T cells find strength in polyfunction

Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia

Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism

Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy

CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Advances in CAR T cell clinical development

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma

At The Bedside: Clinical review of chimeric antigen receptor (CAR) T cell therapy for B cell malignancies

Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience

Suchergebnisse filtern